» Articles » PMID: 33740463

Integrated Collection of Stem Cell Bank Data, a Data Portal for Standardized Stem Cell Information

Abstract

The past decade has witnessed an extremely rapid increase in the number of newly established stem cell lines. However, due to the lack of a standardized format, data exchange among stem cell line resources has been challenging, and no system can search all stem cell lines across resources worldwide. To solve this problem, we have developed the Integrated Collection of Stem Cell Bank data (ICSCB) (http://icscb.stemcellinformatics.org/), the largest database search portal for stem cell line information, based on the standardized data items and terms of the MIACARM framework. Currently, ICSCB can retrieve >16,000 cell lines from four major data resources in Europe, Japan, and the United States. ICSCB is automatically updated to provide the latest cell line information, and its integrative search helps users collect cell line information for over 1,000 diseases, including many rare diseases worldwide, which has been a formidable task, thereby distinguishing itself from other database search portals.

Citing Articles

The Management of Data for the Banking, Qualification, and Distribution of Induced Pluripotent Stem Cells: Lessons Learned from the European Bank for Induced Pluripotent Stem Cells.

Mah N, Kurtz A, Fuhr A, Seltmann S, Chen Y, Bultjer N Cells. 2023; 12(23).

PMID: 38067184 PMC: 10705942. DOI: 10.3390/cells12232756.


A double encryption protection algorithm for stem cell bank privacy data based on improved AES and chaotic encryption technology.

Wang L, Wei X, Zhang Y, Gao Y, Niu Q PLoS One. 2023; 18(10):e0293418.

PMID: 37878640 PMC: 10681628. DOI: 10.1371/journal.pone.0293418.


Human-specific genetics: new tools to explore the molecular and cellular basis of human evolution.

Pollen A, Kilik U, Lowe C, Camp J Nat Rev Genet. 2023; 24(10):687-711.

PMID: 36737647 PMC: 9897628. DOI: 10.1038/s41576-022-00568-4.


Human pluripotent stem cell registry: Operations, role and current directions.

Kurtz A, Mah N, Chen Y, Fuhr A, Kobold S, Seltmann S Cell Prolif. 2022; 55(8):e13238.

PMID: 35522426 PMC: 9357359. DOI: 10.1111/cpr.13238.


Decellularized Organ-Derived Scaffold Is a Promising Carrier for Human Induced Pluripotent Stem Cells-Derived Hepatocytes.

Kojima H, Yagi H, Kushige H, Toda Y, Takayama K, Masuda S Cells. 2022; 11(8).

PMID: 35455938 PMC: 9025569. DOI: 10.3390/cells11081258.

References
1.
Thirumala S, Goebel W, Woods E . Clinical grade adult stem cell banking. Organogenesis. 2010; 5(3):143-54. PMC: 2781095. DOI: 10.4161/org.5.3.9811. View

2.
Andrews P, Baker D, Benvinisty N, Miranda B, Bruce K, Brustle O . Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI). Regen Med. 2015; 10(2 Suppl):1-44. DOI: 10.2217/rme.14.93. View

3.
Sasaki K, Makiyama T, Yoshida Y, Wuriyanghai Y, Kamakura T, Nishiuchi S . Patient-Specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia. PLoS One. 2016; 11(10):e0164795. PMC: 5072719. DOI: 10.1371/journal.pone.0164795. View

4.
Knoppers B, Isasi R . Stem cell banking: between traceability and identifiability. Genome Med. 2010; 2(10):73. PMC: 2988448. DOI: 10.1186/gm194. View

5.
Isasi R, Knoppers B . From banking to international governance: fostering innovation in stem cell research. Stem Cells Int. 2011; 2011:498132. PMC: 3167189. DOI: 10.4061/2011/498132. View